+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

In-Vitro Colorectal Cancer Screening Tests - Global Market Trajectory & Analytics

  • ID: 5028039
  • Report
  • April 2021
  • Region: Global
  • 281 Pages
  • Global Industry Analysts, Inc
Global In-Vitro Colorectal Cancer Screening Tests Market to Reach $1.1 Billion by 2027

Amid the COVID-19 crisis, the global market for In-Vitro Colorectal Cancer Screening Tests estimated at US$879.1 Million in the year 2020, is projected to reach a revised size of US$1.1 Billion by 2027, growing at a CAGR of 3.5% over the analysis period 2020-2027. Fecal Occult Blood Test, one of the segments analyzed in the report, is projected to record a 3.7% CAGR and reach US$851.9 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Biomarker Test segment is readjusted to a revised 2.8% CAGR for the next 7-year period.



The U.S. Market is Estimated at $237.3 Million, While China is Forecast to Grow at 6.3% CAGR

The In-Vitro Colorectal Cancer Screening Tests market in the U.S. is estimated at US$237.3 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$233.7 Million by the year 2027 trailing a CAGR of 6.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1% and 2.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1.7% CAGR.

CRC DNA Screening Test Segment to Record 3.1% CAGR

In the global CRC DNA Screening Test segment, USA, Canada, Japan, China and Europe will drive the 2.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$39.6 Million in the year 2020 will reach a projected size of US$47.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$156.2 Million by the year 2027, while Latin America will expand at a 3.9% CAGR through the analysis period.

Select Competitors (Total 44 Featured):
  • Abbott Laboratories, Inc.
  • Alere, Inc.
  • Beckman Coulter, Inc.
  • Clinical Genomics Technologies Pty Ltd.
  • Eiken Chemical Co., Ltd.
  • Epigenomics AG
  • Exact Sciences Corporation
  • Hemosure, Inc.
  • Novigenix SA
  • Quidel Corporation
  • Sysmex Corporation
Frequently Asked Questions about the Global Market for In-Vitro Colorectal Cancer Screening Tests

What is the estimated value of the Global Market for In-Vitro Colorectal Cancer Screening Tests?

The Global Market for In-Vitro Colorectal Cancer Screening Tests was estimated to be valued at $879.1 Million in 2020.

What is the growth rate of the Global Market for In-Vitro Colorectal Cancer Screening Tests?

The growth rate of the Global Market for In-Vitro Colorectal Cancer Screening Tests is 3.3%, with an estimated value of $1100.0 Million by 2027.

What is the forecasted size of the Global Market for In-Vitro Colorectal Cancer Screening Tests?

The Global Market for In-Vitro Colorectal Cancer Screening Tests is estimated to be worth $1100.0 Million by 2027.
Note: Product cover images may vary from those shown
I. METHODOLOGY

II. EXECUTIVE SUMMARY
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Colorectal Cancer: Symptoms, Causes & Risk Factors
  • Screening for Colorectal Cancer
  • In-Vitro Colorectal Cancer Screening Tests
  • Fecal Occult Blood Test
  • Biomarker Test
  • CRC DNA Screening Test
  • Global Market Prospects & Outlook
  • Fecal Occult Blood Tests Dominate Market
  • Rising Incidence of Colorectal Cancer Drives Market Growth
  • Exhibit 1: Number of New Cancer Cases and Number of Deaths by Type of Cancer in 2020
  • Exhibit 2: Countries with Highest Rate of Colorectal Cancer: Age-Standardized Cases Per 100000 Population
  • Exhibit 3: Colorectal Cancer Rates In Men by Country
  • Exhibit 4: Colorectal Cancer Rates In Women by Country
  • Aging Demographics & Rising Prevalence of Chronic Disorders Enhance Risk of Colorectal Cancer, Necessitating Screening Tests
  • Exhibit 5: Global Aging Population: 65+ Individuals by Region for 2019 and 2050
  • Exhibit 6: Life Expectancy at Birth and at 65 Age by Region
  • Launch of Novel Screening Tests for Detection of Inherited Colorectal Cancer to Spur Gene Testing
  • Market to Benefit from Technological Advancements in Cancer Screening Techniques
  • R&D Investments in Development of Advanced DNA Sequencing Methods to Drive Market Opportunities
  • Biomarker Tests for Colorectal Cancer Screening
  • Molecular Markers Gain Prominence for Colorectal Cancer Screening
  • Rising Need for Minimally Invasive Colorectal Cancer Screening Tests Drives Demand for Genetic and DNA Biomarkers
  • At-Home Screening Test for Colorectal Cancer
  • Government Regulations & Guidelines on Cancer Screening: Potential for Growth

III. MARKET ANALYSIS

IV. COMPETITION
  • Total Companies Profiled: 44
Note: Product cover images may vary from those shown